Skip to main content

New Products

  • No7 Men at Walgreens, Duane Reade

    DEERFIELD, Ill. — Looking to further meet the grooming needs of its male shoppers and further leverage the increased focus on men’s facial skin care, Walgreens debuted earlier this year Boots’ No7 Men+ chain-wide at Walgreens and Duane Reade stores nationwide.

    The six-SKU collection includes No7 Men Protect & Perfect Intense Serum, No7 Men Rapid Revival Eye Roll On and No7 Men Energising Face Wash.

  • Charge on the go with new Rayovac line

    MIDDLETON, Wis. — Spectrum Brands Holdings’ Rayovac battery division recently launched a new line of portable charging products, including the Rayovac 2-Hour Power mobile charging device, which provides instant power to Apple and Micro USB mobile devices. Other new products are the 7-Hour Back-Up Power Pack, the Phone Boost Keychain Charger and portable USB Car & Wall Chargers.

  • Updated Fitbit provides seamless integration

    SAN FRANCISCO — Fitbit in May released the Fitbit Flex, an activity-tracking wristband that syncs wirelessly on-the-go via Bluetooth 4.0 to select iOS and Android devices. Users can seamlessly make fitness and wellness a part of their everyday lifestyle and check their stats from anywhere.

  • King introduces Candy Crush Candies

    NEW YORK - King, a gaming company, is taking Candy Crush sweets from computer and smartphone screens all the way to store shelves with the introduction of Candy Crush Candies.

    The candies, which come in flavors like Jelly Fish, Mixed Fruit Gummies, Sour Fruit Gummies and Color Bombs, are inspired by King's popular game Candy Crush Saga.

  • Topricin addition soothes foot, ankle pain

    RHINEBECK, N.Y. — Topical BioMedics recently gained distribution for its Topricin Foot Therapy Cream, a homeopathic topical treatment for pain associated with fibromyalgia and neuropathy that is safe for diabetics. The cream has been specially formulated to address issues associated with foot and ankle pain and injuries.

  • FDA approves Sunovion's Aptiom as add-on therapy for epilepsy

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating epileptic seizures, the agency said Friday.

    The FDA announced the approval of Aptiom (eslicarbazepine acetate), made by Sunovion Pharmaceuticals, as an add-on medication for seizures in adults. About 200,000 new cases of seizures and epilepsy occur in the United States each year, according to the FDA.

  • Innovation debuts PharmASSIST Dispenser Model 4

    JOHNSON CITY, N.Y. — Pharmacy automation products manufacturer Innovation has started rolling out the latest model of its medication dispensing system, the company said Thursday.

  • Aisle7 launches interactive solution that helps educate patients on nutrient-drug interactions

    PORTLAND, Ore. — Aisle7 on Thursday announced the launch of Healthnotes Interactions Checker, a next-generation solution simplifying the task of deciding which nutrients positively or negatively interact with the medicines they take. More than half of all Americans take some form of dietary supplement, and an estimated 40% of U.S. adults take both drugs and nutrients as part of their health regimen. Of these, 60% aren’t discussing possible interactions with their physician or pharmacist, Aisle7 noted. 

X
This ad will auto-close in 10 seconds